These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 19685375)

  • 1. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
    Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
    Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
    Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
    Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-aged men.
    Yusof HM; Miles EA; Calder P
    Prostaglandins Leukot Essent Fatty Acids; 2008 Mar; 78(3):219-28. PubMed ID: 18403189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of n-3 polyunsaturated fatty acids on soluble cellular adhesion molecules as biomarkers of cardiovascular risk in young healthy subjects.
    Paulo MC; Andrade AM; Andrade ML; Morais MG; Kiely M; Parra D; Martinéz JA; Thorsdottir I; Bandarra NM
    Nutr Metab Cardiovasc Dis; 2008 Dec; 18(10):664-70. PubMed ID: 18420395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease.
    Berrettini M; Parise P; Ricotta S; Iorio A; Peirone C; Nenci GG
    Thromb Haemost; 1996 Mar; 75(3):395-400. PubMed ID: 8701396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study.
    Dyerberg J; Eskesen DC; Andersen PW; Astrup A; Buemann B; Christensen JH; Clausen P; Rasmussen BF; Schmidt EB; Tholstrup T; Toft E; Toubro S; Stender S
    Eur J Clin Nutr; 2004 Jul; 58(7):1062-70. PubMed ID: 15220949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
    Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
    Cas Lek Cesk; 2005; 144(11):737-41. PubMed ID: 16335699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
    Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of modest doses of omega-3 fatty acids on lipids and lipoproteins in hypertriglyceridemic subjects. A randomized controlled trial.
    Deck C; Radack K
    Arch Intern Med; 1989 Aug; 149(8):1857-62. PubMed ID: 2669667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia.
    Castro IA; Monteiro VC; Barroso LP; Bertolami MC
    Nutrition; 2007 Feb; 23(2):127-37. PubMed ID: 17234506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of n - 3 PUFA/gamma-cyclodextrin complex on serum lipids in healthy volunteers--a randomized, placebo-controlled, double-blind trial.
    Kobayashi K; Hamazaki K; Fujioka S; Terao K; Yamamoto J; Kobayashi S
    Asia Pac J Clin Nutr; 2007; 16(3):429-34. PubMed ID: 17704023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II.
    Garg ML; Blake RJ; Clayton E; Munro IA; Macdonald-Wicks L; Singh H; Moughan PJ
    Eur J Clin Nutr; 2007 Nov; 61(11):1312-7. PubMed ID: 17299483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
    Goyens PL; Mensink RP
    Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.
    Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
    J Nutr Biochem; 2006 Jun; 17(6):379-84. PubMed ID: 16214329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
    Leigh-Firbank EC; Minihane AM; Leake DS; Wright JW; Murphy MC; Griffin BA; Williams CM
    Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of marine n-3 fatty acid formulations.
    Dyerberg J; Madsen P; Møller JM; Aardestrup I; Schmidt EB
    Prostaglandins Leukot Essent Fatty Acids; 2010 Sep; 83(3):137-41. PubMed ID: 20638827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
    Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
    Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.